Stay updated on AZD5991 and Venetoclax Combo in Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the AZD5991 and Venetoclax Combo in Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AZD5991 and Venetoclax Combo in Hematologic Malignancies Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-07T12:59:23.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.1 to v3.4.2; no visible changes to the study details or layout.
    Difference
    0.1%
    Check dated 2026-02-14T01:58:57.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Footer revision tag updated from v3.4.0 to v3.4.1, a minor update that does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-06T17:40:18.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Show glossary and Hide glossary options were added. The footer text was updated to Revision: v3.4.0 and No FEAR Act Data, replacing the previous phrasing such as 'Last Update Submitted that met QC Criteria' and Revision: v3.3.4.
    Difference
    0.3%
    Check dated 2026-01-23T10:16:19.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    - Revision: v3.3.4 replaces the previous v3.3.3 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-16T06:41:52.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Introduces a unified Locations section listing California, Colorado, Georgia, Massachusetts, Missouri, New York, Ohio, Oregon, Tennessee, and Texas, replacing the former per-state location subsections.
    Difference
    1%
    Check dated 2025-12-17T19:59:36.000Z thumbnail image

Stay in the know with updates to AZD5991 and Venetoclax Combo in Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AZD5991 and Venetoclax Combo in Hematologic Malignancies Clinical Trial page.